{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:48:14Z","timestamp":1754153294937,"version":"3.41.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/igc.0b013e31823d1b5c","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T08:55:34Z","timestamp":1327395334000},"page":"579-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinicopathologic Characteristics and Survival in BRCA1- and BRCA2-Related Adnexal Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Welmoed","family":"Reitsma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaske A.","family":"ten Hoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Hollema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian J.E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0005","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2000.6095","article-title":"A genetic epidemiological study of carcinoma of the fallopian tube","volume":"80","author":"Aziz","year":"2001","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0035","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-associated and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0040","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/annonc\/mdq628","article-title":"Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients","volume":"22","author":"Vencken","year":"2011","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0050","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1525-1438.1997.00455.x","article-title":"Fallopian tube carcinoma: an under-recognized primary neoplasm","volume":"7","author":"Woolas","year":"1997","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry","volume":"23","author":"Werness","year":"2004","journal-title":"Int J Gynecol Pathol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1025700807451","article-title":"Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study","volume":"2","author":"Piek","year":"2003","journal-title":"Fam Cancer."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","article-title":"Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective","volume":"53","author":"Jarboe","year":"2008","journal-title":"Histopathology."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0080","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0085","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2005.01.039","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations","volume":"97","author":"Casey","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2004.10.017","article-title":"Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense?","volume":"96","author":"Olivier","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0105","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0110","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1158\/1055-9965.EPI-07-2792","article-title":"Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer","volume":"17","author":"Byrd","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1097\/IGC.0b013e31823d1b5c_bb0115","first-page":"868","article-title":"Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"59","author":"Pharoah","year":"1999","journal-title":"Cancer Res."},{"issue":"suppl 1","key":"10.1097\/IGC.0b013e31823d1b5c_bb0120","first-page":"18","article-title":"Stageand CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center","volume":"16","author":"Board","year":"2006","journal-title":"Int J Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24088418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24088418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:17:52Z","timestamp":1753222672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24088418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1048891X24088418"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31823d1b5c","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic Characteristics and Survival in BRCA1- and BRCA2-Related Adnexal Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31823d1b5c","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}